Cardio Explorer

Product deatails

Cardio Explorer offers a non-invasive cardio test to detect life-threatening narrowing in the coronary arteries — the main cause of heart attacks.

Share with us:

Product Description

AI-Powered Cardio Test for Cardiovascular Screening

Heart disease is a leading cause of morbidity worldwide, and early detection is key to prevention. That’s why we are proud to offer Cardio Explorer, our advanced non-invasive cardio test designed to accurately detect the narrowing of the coronary arteries. With high accuracy comparable to the best imaging techniques, Cardio Explorer not only identifies potential risks but also provides efficient risk stratification, allowing healthcare professionals to tailor treatment plans based on individual patient needs.

With high impressive accuracy (AUC of 0.87) rivaling the best imaging techniques, Cardio Explorer empowers both physicians and patients with precise insights and reliable results. It’s designed to meet ESC 2024 guidelines with higher precision, aiding in efficient risk stratification for suspected coronary heart disease (CHD).

Advantages for medical professionals

Highest accuracy (AUC of 0.87)

With an Area Under the Curve (AUC) of 0.87, Cardio Explorer has an accuracy comparable to the best imaging techniques.

No process adjustment is necessary

Cardio Explorer calculates the pre-test probability required by medical guidelines (ESC 2019) with higher precision than existing methods.

Risk stratification: Relieving the burden of care

Cardio Explorer enables precise risk stratification of patients with suspected CHD. This conserves scarce specialist resources and treats patients efficiently.

Broad validation in high and low prevalence populations

Cardio Explorer has been validated in three clinical trials with over 2,000 patients, in high- and low-prevalence populations, and showed tremendously high accuracy in all studies (AUC of 0.87). The broad validation is a prerequisite for use in primary diagnostics and prevention.

Personalized medicine

CHD reflects a system-wide and highly complex pathophysiology that requires a comprehensive combinatorial assessment of all risk factors. Artificial Intelligence (AI) allows efficient and personalized assessment.